Joanna Ewa Sowa, MSc - 2022
DOCTORAL DISERTATION
The involvement of chosen chemokines in neuronal properties and
synaptic transmission
in central and basolateral complex of the rat
amygdala
Joanna Ewa Sowa
Department of Fizjology Maj Institue of Pharmacology Polish Academy of Science
Chemokines are emerging as key players in a broad array of biological responses in the brain
under physiological, non-inflammatory conditions. They can be found in all brain cells - from
brain-blood barrier endothelium, through all types of glia, to neurons and neural stem cells.
Neuron-glia crosstalk is also suggested to be modulated by chemokines. It should be noted that
glial cells not only express chemokine receptors but also can dynamically release them, thus
influencing the activity of neurons or other brain cells. This orchestration of neuron-glia
communication is believed to be essential in maintaining brain homeostasis. Among them,
CX3CL1 and CXCL12 have attracted much attention by demonstrating their role in such
phenomena as neurogenesis, neuroprotection, as well as modulation of synaptic transmission
and plasticity. The relatively high expression of their receptors, i.e., CX3CR1 and CXCR4, in
limbic brain structures supports the association between them and neuropsychiatric diseases,
such as anxiety or depression. Consistently, the impairment of CX3CL1/CX3CR1 and/or
CXCL12/CXCR4 signaling led to behavioral of neurobiological consequences, such as impaired
learning or anxiety. Despite this, mechanisms of chemokines in the regions involved in anxiety
(such as the amygdala) remain largely unknown. It would provide critical insight into the
physiological mechanisms underlying neuroimmunological interactions in the amygdala.
The aim of this study was to dissect the underlying mechanisms and effects of activation of
CX3CR1 and CXCR4 receptors on synaptic transmission and electrophysiological property of
neurons in two nuclei of the amygdala - basolateral (BLA) - the main input nucleus, and central
(CeA) - the main output nucleus.
To this end, by using a combination of electrophysiological and pharmacological approaches,
the actions of two chemokines (CX3CL1 and CXCL12) on neuronal properties as well as synaptic
transmission were determined. Moreover, the involvement of microglia or astrocytes was
measured by using minocycline or fluorocitrate, respectively. In order to confirm the neuronal
expression of CX3CR1, immunohistochemical staining was used.
In the BLA, CX3CL1 increased the threshold for spike generation, reducing the neuronal
excitability of principal cells (PCs). This effect was accompanied by the impaired LTP at corticoBLA synapses and attenuated GABAergic transmission manifested as a decreased frequency of
spontaneous inhibitory synaptic currents (sIPSCs). These effects were blocked in the presence
of the CX3CR1 antagonists, AZD8797. The treatment of the inhibitor of microglial activity,
minocycline, eliminated the CX3CL1-triggered effects. These results suggest that the CX3CR1
activation might modulate the memory and emotional processing via its involvement in the
GABAergic transmission and the attenuation of the PCs firing and synaptic plasticity.
In the CeA, CX3CL1 decreased the input resistance of Regular-Spiking neurons (RS), resulting in
the attenuation of their spiking. The firing reduction of RS neurons consequently reduced the
frequency of sIPSCs in Late-Firing cells (LF). Those effects were eliminated in the presence of
the antagonist of the CX3CR1 receptor, AZD8797, or minocycline, the inhibitor of microglial
activity. Thus, the network activity in the CeA is suggested to be, at least in part, modulated by
the CX3CR1 activation.
The treatment of CXCL12 in the BLA triggered a nonsignificant increase in the PCs excitability
and dual changes in the inhibitory synaptic transmission. These changes are in line with the
CXCL12-induced increase in glutamatergic transmission observed by other group.
CXCL12 enhanced firing in both types of CeA neurons. The application of this chemokine
facilitated the sEPSCs frequency preferentially onto Regular-Spiking neurons. Those effects
were eliminated in the presence of the CXCR4 antagonist, AMD3100. The CXCR4 activation
triggered an increased frequency of sIPSCs onto Regular-Spiking neurons, whereas the
amplitude of these events in Late-Firing neurons was reduced. Those effects were blocked in
the presence of a CXCR4 receptor antagonist and by inhibition of astrocytic activity by
fluorocitrate.
Altogether, findings from this study highlight the neuromodulatory role of CX3CL1 and CXCL12
in both nuclei of the amygdala, which is a consequence of their regulation of local neuron-glial
communication. Further investigation in this area will lead to a better understanding of
neuroimmunological mechanisms in the amygdala and provide novel insights into neuroimmune mechanisms in the amygdala and yield new targets for developing treatments of
amygdala-related disorders
Files to download
- 602.604 kB Streszczenie rozprawy_J.E.Sowa.pdf
- 284.374 kB Recenzja_J.E.Sowa_M.H.Lewandowski.pdf
- 1974.995 kB Recenzja_J.E.Sowa_P.Maciejak.pdf